Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)

Hematology and Cell Therapy

Volumn 38, Issue 2, 1996, Pages 169-176

  Michel, G ^a   Baruchel, A ^b   Tabone, M D ^c   Nelken, B ^d   Leblanc, T ^b   Thuret, I ^a   Bordigoni, P ^e   Bergeron, C ^f   Esperou Bourdeau, H ^b   Perel, Y ^g   Vannier, J P ^h   De Lumley, L ⁱ   Dommergues, J P ^j   Lamagnere J P ^k   Couillaud, G ^l   Auvrignon, A ^c   Schaison, G ^b   Leverger, G ^c  

^a Hôpital d'Enfants   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e HÔPITAL D ENFANTS   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g Hôpital d'Enfants de Bordeaux   (France)

^h HÔPITAL CHARLES NICOLLE   (France)

ⁱ LIMOGES UNIVERSITY HOSPITAL   (France)

^j BICÊTRE HOSPITAL   (France)

^k Centre de Pediatrie Clocheville   (France)

^l Hôpital de Dijon   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SURVIVAL;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0030047489     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0169-7     Document Type: Article

References (25)

1. Amadori S. Testi AM, Arico M et al (1993) Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogeneous leukemia. J Clin Oncol 11 : 1046-1054
2. Bostrom B, Brunning RD, Mac Glave P et al (1985) Bone marrow transplantation for acute nonlymphoblastic leukemia in first remission: analysis of prognostic factors. Blood 65 : 1191-1196
3. Brochstein JA, Kernan NA, Groshen S et al (1987) Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Eng J Med 17 : 1618-1624
4. Clift R, Goldman JM, Gratwohl A, Horowitz M (1989) Proposals for standardized reporting of results of bone marrow transplantation for leukemia. Bone Marrow Transplant 4 : 445-448
5. Copeland EA, Biggs JC, Thompson JM et al (1991) Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 78 : 838-843
6. Cox DR (1972) Regression models and life tables. J R Stat Soc 34 : 187-202
7. Dahl GV, Kalwinski DK, Mirro J et al (1990) Allogeneic bone marrow transplantation in a program of intensive sequencial chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8 : 295-303
8. Dini G, Abla O, Uderzo C et al (1991) Allogeneic bone marrow transplantation in children with ANLL: Italian experience. Bone Marrow Transplant 7 [Suppl 3] : 76-79
9. Dinsmore R, Kirkpatrick D, Flomenberg N et al (1984) Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemia. Blood 63 : 649-656
10. Feig SA, Lampkin B, Nesbit ME et al (1993) Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the children's Cancer Group. Bone Marrow Transplant 12 : 65-71
11. Feig SA, Nesbit ME, Buckley J et al (1987) Bone marrow transplantation for acute non-lymphocytic leukemia: a report from the Children Cancer Study Group of sixty-seven children transplanted in first remission. Bone Marrow Transplant 2 : 365-374
12. Forman AJ, Krance RA, O'Donnell MR et al (1987) Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. Transplantation 43 : 650-653
13. Glucksberg H, Storb R, Fefer A et al (1974) Clinical manifestations of graft-vs-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18 : 295-304
14. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 : 457-481
15. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 : 163-170
16. Michel G, Gluckman E, Biaise D et al (1992) Improvement in outcome for children receiving allogeneic bone marrow transplantation in first complete remission of acute myeloïd leukemia. A report from the GEGMO. J Clin Oncol 10 : 1865-1869
17. Nesbit ME, Buckley JD, Feig SA et al (1994) Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: A report from the Childrens Cancer Group. J Clin Oncol 12 : 127-135
18. Sanders JE, Thomas ED, Buckner CD et al (1985) Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood 66 : 460-462
19. Santos GW, Tutschka PJ, Brookmeyer R et al (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulphan and cyclophosphamide. N Engl J Med 309 : 1347-1353
20. Shulman HM, Sullivan KM, Weiden PL et al(1980) Chronic graft-vs-host syndrome in man: A long-term clinico-pathologic study of 20 Seattle patients. Am J Med 69 : 204-217
21. Schwartz D (1969) Méthodes statistiques à l'usage des médecins et des biologistes. In: Schwartz D (ed) Flammarion, Paris
22. Wells RJ, Woods WG, Buckley JD et al (1994) Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A children cancer group study. J Clin Oncol 12 : 2367-2377
23. Wells RJ, Woods WG, Lampkin BC et al (1993) Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: A report from the Childrens Cancer Group. J Clin Oncol 11 : 538-545
24. Woods WG, Ruymann FB, Lampkin BC et al (1990) The role of timing of high dose cytosine arabinosine intensification and of maintenance therapy in the treatment of children with acute nonlymphoblastic leukemia. Cancer 66 : 1106-1113
25. Woods WG, Kobrinsky N, Buckley J et al (1993) Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloïd leukemia or myelodysplastic syndrome : a children cancer group pilot study. J Clin Oncol 11 : 1448-1457